Suivre
Abonner Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee

Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee

Filtre
  • 21.07.2008 – 19:21

    Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study

    London (ots/PRNewswire) - The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively ...

  • 21.07.2008 – 09:06

    Update on the SEAS Study

    London (ots/PRNewswire) - Professor Terje Pedersen (Ullevål University Hospital, Oslo, Norway), lead investigator for the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will provide an update on the study on Monday the 21st July. Also present in London will be Sir Richard Peto (Professor of Medical Statistics and Epidemiology and Co-director of the Clinical Trials Service Unit, University of Oxford) Professor Rory Collins (BHF Professor of Medicine and ...